Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to 0.31.

  • Regenxbio's Equity Ratio fell 4705.65% to 0.31 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31, marking a year-over-year decrease of 4705.65%. This contributed to the annual value of 0.56 for FY2024, which is 259.08% up from last year.
  • As of Q3 2025, Regenxbio's Equity Ratio stood at 0.31, which was down 4705.65% from 0.37 recorded in Q2 2025.
  • In the past 5 years, Regenxbio's Equity Ratio registered a high of 0.69 during Q4 2021, and its lowest value of 0.31 during Q3 2025.
  • For the 5-year period, Regenxbio's Equity Ratio averaged around 0.58, with its median value being 0.61 (2021).
  • Its Equity Ratio has fluctuated over the past 5 years, first soared by 2862.96% in 2021, then crashed by 4705.65% in 2025.
  • Quarter analysis of 5 years shows Regenxbio's Equity Ratio stood at 0.69 in 2021, then decreased by 9.72% to 0.62 in 2022, then dropped by 12.32% to 0.54 in 2023, then grew by 2.59% to 0.56 in 2024, then plummeted by 44.83% to 0.31 in 2025.
  • Its last three reported values are 0.31 in Q3 2025, 0.37 for Q2 2025, and 0.56 during Q1 2025.